Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$101.21 - $166.61 $94,024 - $154,780
-929 Reduced 28.44%
2,338 $277,000
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $19,037 - $25,743
223 Added 7.33%
3,267 $348,000
Q4 2023

Feb 05, 2024

SELL
$69.51 - $104.43 $20,157 - $30,284
-290 Reduced 8.7%
3,044 $302,000
Q3 2023

Nov 06, 2023

SELL
$96.41 - $126.61 $71,343 - $93,691
-740 Reduced 18.16%
3,334 $344,000
Q2 2023

Aug 04, 2023

BUY
$118.5 - $160.53 $201,805 - $273,382
1,703 Added 71.83%
4,074 $494,000
Q1 2023

May 02, 2023

BUY
$135.66 - $197.02 $35,000 - $50,831
258 Added 12.21%
2,371 $364,000
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $46,168 - $81,915
390 Added 22.63%
2,113 $379,000
Q3 2022

Oct 28, 2022

BUY
$118.07 - $194.18 $203,434 - $334,572
1,723 New
1,723 $204,000
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $152,971 - $230,626
-1,306 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$126.46 - $235.05 $16,692 - $31,026
132 Added 11.24%
1,306 $225,000
Q4 2021

Feb 08, 2022

BUY
$225.82 - $368.51 $265,112 - $432,630
1,174 New
1,174 $298,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.